Use of JAK inhibitors in the management of myelofibrosis:a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

Autoria(s): Reilly, John T; McMullin, Mary Frances; Beer, Philip A; Butt, Nauman; Conneally, Eibhlin; Duncombe, Andrew S; Green, Anthony R; Mikhaeel, George; Gilleece, Marie H; Knapper, Steven; Mead, Adam J; Mesa, Ruben A; Sekhar, Mallika; Harrison, Claire N
Data(s)

25/06/2014
Identificador

http://pure.qub.ac.uk/portal/en/publications/use-of-jak-inhibitors-in-the-management-of-myelofibrosis(eda9818c-7069-43cd-b284-d54dc2ab81f3).html

http://dx.doi.org/10.1111/bjh.12985
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Reilly , J T , McMullin , M F , Beer , P A , Butt , N , Conneally , E , Duncombe , A S , Green , A R , Mikhaeel , G , Gilleece , M H , Knapper , S , Mead , A J , Mesa , R A , Sekhar , M & Harrison , C N 2014 , ' Use of JAK inhibitors in the management of myelofibrosis : a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012 ' British Journal of Haematology . DOI: 10.1111/bjh.12985
Tipo

article
Acesso ao item digital